These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 3399498)

  • 1. Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system.
    Tam JP
    Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5409-13. PubMed ID: 3399498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application and limitations of the multiple antigen peptide (MAP) system in the production and evaluation of anti-peptide and anti-protein antibodies.
    Briand JP; Barin C; Van Regenmortel MH; Muller S
    J Immunol Methods; 1992 Dec; 156(2):255-65. PubMed ID: 1474260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemically unambiguous peptide immunogen: preparation, orientation and antigenicity of purified peptide conjugated to the multiple antigen peptide system.
    Lu YA; Clavijo P; Galantino M; Shen ZY; Liu W; Tam JP
    Mol Immunol; 1991 Jun; 28(6):623-30. PubMed ID: 1861679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel method for producing anti-peptide antibodies. Production of site-specific antibodies to the T cell antigen receptor beta-chain.
    Posnett DN; McGrath H; Tam JP
    J Biol Chem; 1988 Feb; 263(4):1719-25. PubMed ID: 3276675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipophilic multiple antigen peptide system for peptide immunogen and synthetic vaccine.
    Huang W; Nardelli B; Tam JP
    Mol Immunol; 1994 Oct; 31(15):1191-9. PubMed ID: 7935506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple antigen peptide. A novel approach to increase detection sensitivity of synthetic peptides in solid-phase immunoassays.
    Tam JP; Zavala F
    J Immunol Methods; 1989 Nov; 124(1):53-61. PubMed ID: 2809228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of polyclonal antibodies to the Ah receptor prepared by immunization with a synthetic peptide hapten.
    Poland A; Glover E; Bradfield CA
    Mol Pharmacol; 1991 Jan; 39(1):20-6. PubMed ID: 1846218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Affinity purification of polyclonal antibodies using immobilized multimeric peptides.
    Verdoliva A; Cassani G; Fassina G
    J Chromatogr B Biomed Appl; 1995 Feb; 664(1):175-83. PubMed ID: 7757223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody Production with Synthetic Peptides.
    Lee BS; Huang JS; Jayathilaka LP; Lee J; Gupta S
    Methods Mol Biol; 2016; 1474():25-47. PubMed ID: 27515072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and immunological properties of topographic immunogenic determinants of a protein antigen (LDH-C4) as vaccines.
    Kaumaya PT; VanBuskirk AM; Goldberg E; Pierce SK
    J Biol Chem; 1992 Mar; 267(9):6338-46. PubMed ID: 1372905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifertility effect of passive administration of antibodies to 80 kDa human sperm antigen and its synthetic peptides in male and female rats.
    Bandivdekar AH; Vernekar VJ; Kamada M; Raghavan VP
    Am J Reprod Immunol; 2005 Dec; 54(6):332-41. PubMed ID: 16305658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of peptide-immunogens corresponding to amino acid sequences from human histocompatibility class II membrane glycoproteins.
    Chillemi F; Cappelletti S; Francescato P; Chersi A
    Int J Pept Protein Res; 1990 Mar; 35(3):271-80. PubMed ID: 2354878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic peptide vaccines against foot-and-mouth disease. I. Duration of the immune response and priming in guinea-pigs, rabbits and mice.
    Murdin AD; Doel TR
    J Biol Stand; 1987 Jan; 15(1):39-51. PubMed ID: 3031077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic peptides for production of antibodies that recognize intact proteins.
    Grant GA
    Curr Protoc Immunol; 2003 Aug; Chapter 9():Unit 9.2. PubMed ID: 18432915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
    Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
    J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of sequence specific polyclonal antibodies to human parathyroid hormone 1-37 by immunization with multiple antigenic peptides.
    Mägerlein M; Hock D; Adermann K; Neidlein R; Forssmann WG; Strein K
    Arzneimittelforschung; 1998 Jul; 48(7):783-7. PubMed ID: 9706380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of synthetic peptides derived from Plasmodium falciparum proteins.
    Zerpa NC; Wide A; Noda J; Bermúdez H; Pabón R; Noya OO
    Exp Parasitol; 2006 Aug; 113(4):227-34. PubMed ID: 16513113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic peptide vaccines: palmitoylation of peptide antigens by a thioester bond increases immunogenicity.
    Beekman NJ; Schaaper WM; Tesser GI; Dalsgaard K; Kamstrup S; Langeveld JP; Boshuizen RS; Meloen RH
    J Pept Res; 1997 Nov; 50(5):357-64. PubMed ID: 9401920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple antigen peptides (MAPs) as candidate vaccines against malaria.
    Pessi A; Bianchi E; Chiappinelli L; Bonelli F; Tougne C; Lambert PH; Del Giudice G
    Parassitologia; 1991 Apr; 33(1):79-84. PubMed ID: 1668679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The N-terminal peptide of the hexon of human adenovirus type 2: its chemical synthesis and antigenic properties].
    Tarasishin LA
    Mikrobiol Zh (1978); 1991; 53(5):53-8. PubMed ID: 1724282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.